Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiang Fu

Showing results (441-450 of 451) with videos related to

Pageof 46
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2012
ERG rearrangement for predicting subsequent cancer diagnosis in high-grade prostatic intraepithelial neoplasia and lymph node metastasisXin Gao, Liao-Yuan Li, Fang-Jian Zhou, et al.
European Journal of Medicinal Chemistry|March 10, 2023
From PROTAC to inhibitor: Structure-guided discovery of potent and orally bioavailable BET inhibitorsMladen Koravovic, Anand Mayasundari, Gordana Tasic, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Hidden-driver inference reveals synergistic brain-penetrant therapies for medulloblastomaJingjing Liu, Xu Yang, Mingrui Zhu, et al.
Angewandte Chemie (International Ed. in English)|February 13, 2020
RASS-Enabled S/P-C and S-N Bond Formation for DEL SynthesisDillon T Flood, Xuejing Zhang, Xiang Fu, et al.
Nature Biomedical Engineering|October 5, 2023
Control of the antitumour activity and specificity of CAR T cells via organic adapters covalently tethering the CAR to tumour cellsAlexey V Stepanov, Jia Xie, Qiaoqiao Zhu, et al.
Nature|January 17, 2025
A generative model for inorganic materials designClaudio Zeni, Robert Pinsler, Daniel Zügner, et al.
Journal of Medicinal Chemistry|January 15, 2025
Evaluation of Cereblon-Directing Warheads for the Development of Orally Bioavailable PROTACsMarisa Actis, Joel Cresser-Brown, Elizabeth A Caine, et al.
Journal of Medicinal Chemistry|May 27, 2021
Identification of Potent, Selective, and Orally Bioavailable Small-Molecule GSPT1/2 Degraders from a Focused Library of Cereblon ModulatorsGisele Nishiguchi, Fatemeh Keramatnia, Jaeki Min, et al.
Angewandte Chemie (International Ed. in English)|October 6, 2021
Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACsJaeki Min, Anand Mayasundari, Fatemeh Keramatnia, et al.
Acta Neuropathologica Communications|February 15, 2022
Antemortem detection of Parkinson's disease pathology in peripheral biopsies using artificial intelligenceMaxim Signaevsky, Bahram Marami, Marcel Prastawa, et al.
Pageof 46

Showing results (441-450 of 451) with videos related to

Sort By:
Pageof 46
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2012
ERG rearrangement for predicting subsequent cancer diagnosis in high-grade prostatic intraepithelial neoplasia and lymph node metastasisXin Gao, Liao-Yuan Li, Fang-Jian Zhou, et al.
European Journal of Medicinal Chemistry|March 10, 2023
From PROTAC to inhibitor: Structure-guided discovery of potent and orally bioavailable BET inhibitorsMladen Koravovic, Anand Mayasundari, Gordana Tasic, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
Hidden-driver inference reveals synergistic brain-penetrant therapies for medulloblastomaJingjing Liu, Xu Yang, Mingrui Zhu, et al.
Angewandte Chemie (International Ed. in English)|February 13, 2020
RASS-Enabled S/P-C and S-N Bond Formation for DEL SynthesisDillon T Flood, Xuejing Zhang, Xiang Fu, et al.
Nature Biomedical Engineering|October 5, 2023
Control of the antitumour activity and specificity of CAR T cells via organic adapters covalently tethering the CAR to tumour cellsAlexey V Stepanov, Jia Xie, Qiaoqiao Zhu, et al.
Nature|January 17, 2025
A generative model for inorganic materials designClaudio Zeni, Robert Pinsler, Daniel Zügner, et al.
Journal of Medicinal Chemistry|January 15, 2025
Evaluation of Cereblon-Directing Warheads for the Development of Orally Bioavailable PROTACsMarisa Actis, Joel Cresser-Brown, Elizabeth A Caine, et al.
Journal of Medicinal Chemistry|May 27, 2021
Identification of Potent, Selective, and Orally Bioavailable Small-Molecule GSPT1/2 Degraders from a Focused Library of Cereblon ModulatorsGisele Nishiguchi, Fatemeh Keramatnia, Jaeki Min, et al.
Angewandte Chemie (International Ed. in English)|October 6, 2021
Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACsJaeki Min, Anand Mayasundari, Fatemeh Keramatnia, et al.
Acta Neuropathologica Communications|February 15, 2022
Antemortem detection of Parkinson's disease pathology in peripheral biopsies using artificial intelligenceMaxim Signaevsky, Bahram Marami, Marcel Prastawa, et al.
Pageof 46